Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cyclin-T1/Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM258854 (US9499492, 6) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description Method 1a: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were pu... | US Patent US9499492 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GW0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cyclin-T1/Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM258854 (US9499492, 6) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 231 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description Method 1b: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were pu... | US Patent US9499492 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GW0 | |||||||||||
More data for this Ligand-Target Pair |